LOGIN
Effect of teriparatide on vertebral fracture risk factors in osteoporosis patients
August 2014
Effect of teriparatide on vertebral fracture risk factors in osteoporosis patients
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
Curr Med Res Opin. 2014 May;30(5):931-6Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
237 elderly men and postmenopausal women, between the ages of 65 and 91 years old, with primary osteoporosis with up to 5 prevalent vertebral fractures caused by low BMD of the lumbar spine, were randomly assigned into 1 of 2 groups, a treatment and a placebo, to determine the effect a once a week administration of 56.6 microgram teriparatide had on bone mineral density and bone turnover markers 7...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.